Exagen Inc. buy BiotechBee
Start price
08.09.24
/
50%
€2.80
Target price
31.05.27
€3.70
Performance (%)
96.43%
End price
14.12.24
€5.50
Summary
This prediction ended on 14.12.24 with a price of €5.50. With a performance of 96.43% the BUY prediction by BiotechBee was a big success. BiotechBee has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Exagen Inc. | - | - | - |
| iShares Core DAX® | -1.212% | 1.925% | 17.589% |
| iShares Nasdaq 100 | -4.714% | -1.810% | 0.450% |
| iShares Nikkei 225® | -2.976% | -2.660% | 10.156% |
| iShares S&P 500 | -2.744% | -0.448% | 0.320% |
According to BiotechBee what are the pros and cons of Exagen Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Exagen Inc. diskutieren
In the thread Trading Exagen Inc.
Stopped prediction by BiotechBee for Exagen Inc.
Exagen Inc.
Start price
Target price
Perf. (%)
€5.55
02.12.23
02.12.23
€2.60
31.12.25
31.12.25
-
04.12.23
04.12.23
Could be very worthwhile Investment >20% year
